SCHEMBL6748303

SCHEMBL6748303

CC/C=C(\CO)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12654720 1.00
SCHEMBL9501032 0.85 CES2 (0.35)
SCHEMBL7927996 0.84 CES1 (0.36)
SCHEMBL7927993 0.84 CES1 (0.36)
SCHEMBL15801481 0.83
SCHEMBL19994697 0.82 CES2 (0.39)
SCHEMBL9219093 0.82
SCHEMBL5868328 0.81 ALDH1A1 (0.36)
SCHEMBL8573776 0.81 SQLE (0.43)
SCHEMBL8573777 0.81 SQLE (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527827-B2 C-9 oxygen functionalized labdane derivates COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-12-27 US disclosed
US-8183005-B1 Pharmaceutical agents for treating HCV infections CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-05-22 US disclosed
US-7378446-B2 Compound having anti-HCV activity and process for producing the same CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-27 US disclosed